Scholarlink

Background <p>Although the prognosis of patients with pediatric intracranial germ cell tumors (ICGCTs) has improved, late effects in long-term survivors remains an important issue. Here, we evaluated endocrine complications and quality of life in ICGCT patients treated with proton beam therapy (PBT) or photon radiotherapy (RT).</p> Methods <p>We retrospectively evaluated 18 patients aged 15&#xa0;years or younger at the time of ICGCT diagnosis at University of Tsukuba Hospital from January 2010 to December 2016.</p> Results <p>Eleven had tumors in the suprasellar region and seven in other parts of the brain (non-suprasellar ICGCT). Ten were treated with proton beam therapy only in combination with chemotherapy. All but 2 patients were alive without disease. The number of cases receiving hormone replacement therapy (HRT) were significantly higher in the suprasellar tumor group (p &lt; 0.001), and longer time to diagnosis (TTD) from onset was associated with the number of hormones being replaced at the last visit (correlation coefficient 0.77, p &lt; 0.001). All the patients who received appropriate growth hormone therapy increased in height without relapse of the tumor. With regard to the modality of radiation therapy for ICGCTs, PBT was equivalent to photon RT in terms of recurrence, survival, number of hormones being replaced, and quality of life.</p> Conclusions <p>HRT was more frequently administered to patients with suprasellar ICGCT than to those with non-suprasellar ICGCT, and was more likely to be required in patients with a longer TTD. Parameters such as radiotherapy and chemotherapy were not associated with HRT in survivors of ICGCTs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Suprasellar CNS germ cell tumors and endocrine sequelae: early growth hormone therapy as a contributor to height gain: a single institute analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月13日

查看全文
  • Ayumi Suda,
  • Hiroko Fukushima,
  • Ayako Takarada,
  • Ryoko Suzuki,
  • Atsushi Iwabuchi,
  • Ai Muroi,
  • Masashi Mizumoto,
  • Hidetoshi Takada

摘要

Background

Although the prognosis of patients with pediatric intracranial germ cell tumors (ICGCTs) has improved, late effects in long-term survivors remains an important issue. Here, we evaluated endocrine complications and quality of life in ICGCT patients treated with proton beam therapy (PBT) or photon radiotherapy (RT).

Methods

We retrospectively evaluated 18 patients aged 15 years or younger at the time of ICGCT diagnosis at University of Tsukuba Hospital from January 2010 to December 2016.

Results

Eleven had tumors in the suprasellar region and seven in other parts of the brain (non-suprasellar ICGCT). Ten were treated with proton beam therapy only in combination with chemotherapy. All but 2 patients were alive without disease. The number of cases receiving hormone replacement therapy (HRT) were significantly higher in the suprasellar tumor group (p < 0.001), and longer time to diagnosis (TTD) from onset was associated with the number of hormones being replaced at the last visit (correlation coefficient 0.77, p < 0.001). All the patients who received appropriate growth hormone therapy increased in height without relapse of the tumor. With regard to the modality of radiation therapy for ICGCTs, PBT was equivalent to photon RT in terms of recurrence, survival, number of hormones being replaced, and quality of life.

Conclusions

HRT was more frequently administered to patients with suprasellar ICGCT than to those with non-suprasellar ICGCT, and was more likely to be required in patients with a longer TTD. Parameters such as radiotherapy and chemotherapy were not associated with HRT in survivors of ICGCTs.